Weill Cornell Genitourinary Cancer Program

05/08/2025

Dr. Jim Hu discusses research showing that transperineal biopsies were superior to the transrectal approach in detecting :

Transperineal biopsies detected more clinically significant cancers and may reduce infection risk, but men complained of more pain and embarrassment.

04/17/2025

Members of our team attended last month where they presented on the latest prostate-specific membrane antigen ( ) coming out of Weill Cornell Medicine. Read more here:

The PSMA & Beyond 2025 Conference returned for its highly anticipated second edition, this time hosted in vibrant Los Angeles, California. Organized by University of California, San Francisco (…

03/03/2025

Sending out an official social media welcome to Dr. Rohit Jain, the newest member of our Weill Cornell/NewYork-Presbyterian Hospital care team! He joined us at the end of 2024, caring for patients with , , & : https://bit.ly/3Xokwhx

11/11/2024

A study led by Dr. Bishoy Faltas Weill Cornell determined that antiviral enzymes that edit the genomes of cells drive the development of early :

Antiviral enzymes that edit the genomes of cancer cells can cause early mutational changes that drive early bladder cancer development.

11/06/2024

Dr. Christopher Barbieri talked to Men's Health about what men should know about treatment options:

Why there are so many, and how they differ.

11/04/2024

ICYMI: New from Dr. Jim Hu found that transperineal biopsies should be the standard of care for the diagnosis of because there were no infections reported with this approach

A new, multicenter, randomized trial showed transperineal biopsies had similar, if not slightly better, outcomes than the transrectal method.

10/30/2024

led by Dr. Jim Hu showed that similar detection rates were seen with transperineal versus transrectal biopsy, but there are reduced infections is a reduction in infections with the transperineal approach:

MONDAY, Sept. 30, 2024 (HealthDay News) -- For patients with suspicion for prostate cancer, transperineal biopsy has similar cancer detection rates as transrect

09/10/2024

Patients and loved ones impacted by are invited to the 2024 to learn about key updates in genetic testing, integrative medicine, and the latest treatments. RSVP today to reserve your seat at this free event: prostatesummit.org

09/03/2024

September is and teams from Weill Cornell Medicine, NewYork-Presbyterian Hospital, Memorial Sloan Kettering Cancer Center, and Columbia University Irving Medical Center are coming together on 9/22 to share important research and treatment updates with the patient community. Reserve your spot: prostatesummit.org

08/27/2024

The is less than a month away! RSVP to learn about the latest in genetic testing, integrative medicine, team-based approaches to care, and much more. The event is free and open to all those impacted by . prostatesummit.org

08/19/2024

The 2024 is right around the corner. Mark your calendar and RSVP to join this free event featuring experts from Weill Cornell Medicine, NewYork-Presbyterian Hospital, Memorial Sloan Kettering Cancer Center, and Columbia University Irving Medical Center to hear the latest updates in care. prostatesummit.org

07/04/2024

Hear Dr. Scott Tagawa speak via Medscape about optimal systemic therapy for advanced ( ) and how treatment options have evolved over time:

Scott T. Tagawa, MD discusses optimal systemic therapy in advanced urothelial cancer